Afya (NASDAQ:AFYA) Stock Price Target Lowered at JPMorgan Chase & Co.

Key Points

• JPMorgan cut Afya’s price target from $19.00 to $17.50 while maintaining an “overweight” rating, implying 67.24% upside from the prior close.
• Analyst sentiment is mixed: Afya has a consensus “Hold” rating and an average target price of $15.70, with four Buy, three Hold, and one Sell rating.
• Afya shares fell 1.7% to $10.46, trading below their 50-day and 200-day moving averages. The company recently exceeded quarterly EPS estimates, reporting $0.43 versus the $0.40 consensus, while revenue came in slightly below expectations.

Afya (NASDAQ:AFYA - Get Free Report) had its price objective cut by stock analysts at JPMorgan Chase & Co. from $19.00 to $17.50 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s target price suggests a potential upside of 67.24% from the company's previous close.

A number of other equities analysts also recently weighed in on AFYA. Wall Street Zen downgraded shares of Afya from a "buy" rating to a "hold" rating in a research note on Saturday. Citigroup raised Afya from a "neutral" rating to a "buy" rating and dropped their price target for the stock from $16.00 to $12.00 in a research report on Tuesday. Bradesco Corretora upgraded Afya to an "outperform" rating and set a $17.00 price target on the stock in a research note on Thursday, September 24th. Bank of America raised Afya from a "neutral" rating to a "buy" rating and set a $16.00 price objective for the company in a research report on Thursday, October 29th. Finally, Weiss Ratings cut Afya from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Thursday. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Afya currently has a consensus rating of "Hold" and an average target price of $15.70.

Afya Stock Down 1.7%

Shares of NASDAQ:AFYA traded down $0.18 during midday trading on Tuesday, reaching $10.46. The company's stock had a trading volume of 124,441 shares, compared to its average volume of 190,302. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39. The firm has a 50 day moving average of $13.55 and a 200-day moving average of $14.18. The firm has a market capitalization of $980.72 million, a P/E ratio of 6.39, a PEG ratio of 1.24 and a beta of 0.34. Afya has a 12-month low of $9.66 and a 12-month high of $16.16.

Afya (NASDAQ:AFYA - Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. Afya had a net margin of 20.55% and a return on equity of 17.58%. The company had revenue of $187.80 million during the quarter, compared to analysts' expectations of $189.62 million. On average, research analysts anticipate that Afya will post 1.72 earnings per share for the current year.

Insider Activity at Afya

In other news, insider Santos Welder Ferreira sold 4,161 shares of the stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $13.30, for a total transaction of $55,341.30. Following the sale, the insider owned 35,000 shares in the company, valued at $465,500. This represents a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Afya

A hedge fund recently bought a new stake in Afya stock. Engineers Gate Manager LP acquired a new stake in Afya Limited (NASDAQ:AFYA - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 21,882 shares of the company's stock, valued at approximately $325,000. 88.02% of the stock is owned by institutional investors and hedge funds.

Afya Company Profile

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.